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Post-translational modiﬁcationNumerous G protein-coupled receptors (GPCRs) are glycosylated at extracellular regions. The regulatory roles of
glycosylation on receptor function vary across receptor types. In this study, we used the dopamine D2 and D3
receptors as an experimental model to understand the underlying principles governing the functional roles of
glycosylation. We used the pharmacological inhibitor, tunicamycin, to inhibit glycosylation, generated chimeric
D2 and D3 receptors by swapping their respective N-termini, and produced the glycosylation site mutant D2 and
D3 receptors to study the roles of glycosylation on receptor functions, including cell surface expression, signaling,
and internalization through speciﬁc microdomains. Our results demonstrate that glycosylation on the N-terminus
of the D3 receptor is involved in the development of desensitization and proper cell surface expression. In addition,
glycosylation on the N-terminus mediates the internalization of D2 and D3 receptors within the caveolae and
clathrin-coated pit microdomains of the plasma membrane, respectively, by regulating receptor interactions with
caveolin-1 and clathrin. In conclusion, this study shows for the ﬁrst time that glycosylation on the N-terminus of
GPCRs is involved in endocytic pathway selection through speciﬁc microdomains. These data suggest that changes
in the cellular environment that inﬂuence posttranslational modiﬁcation could be an important determinant of
intracellular GPCR trafﬁcking.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Extracellular, cytoplasmic, and transmembrane domains are com-
monly found in G protein-coupled receptors (GPCRs). Domain roles in
ligand binding, intracellular trafﬁcking, and signal transduction vary de-
pending on the receptor families of the protein. The GPCR extracellular
domain is composed of N-terminus and extracellular loops. GPCRs
are grouped into several classes based on the organization of their
N-terminus [1]. Because the N-terminus is highly variable in size and
sequence, functional roles of the extracellular domain are less clear
than for other domains [2].
N-linked glycosylation is a highly conserved post-translational
modiﬁcation that occurs on theAsn-X-Ser/Thrmotif on the extracellularcology, College of Pharmacy,
blic of Korea. Tel.: +82 62 530domains of GPCRs [3–5]. The extent of glycosylation and its inﬂuence
on receptor function varies according to receptor type and cellular
environment. Therefore, carefully controlled experiments are necessary
to understand the broader functional roles of glycosylation and the
underlying regulatory mechanisms.
Dopamine D2 and D3 receptors, the primary targets of antipsychotic
drugs, possess high amino acid sequence homology, similar pharmaco-
logical properties, and act similarly in signaling pathways. Despite
pharmacological and functional similarities, D2 and D3 receptor exhibit
distinct intracellular trafﬁcking and desensitization properties [6].
Thus, these two receptors can serve as an excellent experimental
model to assess the broad roles of glycosylation in receptor function,
speciﬁcally cell surface expression, internalization, and signaling.
The human D2 receptor contains three potential N-linked glycosyla-
tion sites, all in the N-terminus: Asn-5, Asn-17, and Asn-23. The D3
receptor has four potential glycosylation sites: Asn-12 and Asn-19 in
the N-terminus, Asn-97 in the ﬁrst extracellular loop, and Asn-173 in
the second extracellular loop. Glycosylation of these receptors was
reported in the porcine pituitary D2 receptor [7] and cloned D2 and D3
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cell surface expression and internalization [10,11]. The functional
roles of glycosylation for the D3 receptor, however, have not been
reported.
The objective of this study was to determine whether a generalized
principle exists to predict the roles of N-linked glycosylation in receptor
function. We hypothesized that distinct N-terminal functions, speciﬁ-
cally characteristic glycosylation patterns, could determine the differen-
tial regulatory properties of these receptors. Parallel and combined
studies of the D2 and D3 receptors demonstrate that N-linked glycosyla-
tion of theN-terminus regulates association of the receptorwith speciﬁc
microdomains in the plasma membrane. Our results reveal a novel
principle governing the control of intracellular GPCR trafﬁcking of
through regulation of N-linked glycosylation.
2. Materials and methods
2.1. Materials
Human embryonic kidney HEK-293 cells were obtained from the
American Type Culture Collection (Rockville, MD, USA). Tissue culture
media and fetal bovine serum were obtained from Life Technologies
(Grand Island,NY, USA). Dopamine (DA), quinpirole, haloperidol, phorbol
12-myristate 13-acetate (PMA), forskolin, methyl-β-cyclodextrins
(MβCD), and antibodies to actin, FLAG, and green ﬂuorescent
protein (GFP) were purchased from Sigma-Aldrich (St. Louis,
MO, USA). Endoglycosidase H (Endo H) and peptide N-glycosidase
F (PNGase F) were purchased from New England Biolabs (Ipswich, MA,
USA). [3H]-Sulpiride (84 Ci/mmol) and [3H]-spiperone (85.5 Ci/mmol)
were purchased from PerkinElmer Life Sciences (Boston, MA, USA).
Tunicamycin, antibodies to GRK2 and clathrin heavy chain, and HRP-
conjugated secondary antibodies were obtained from Santa Cruz
Biotechnology (Santa Cruz, CA, USA). Caveolin-1 antibody was pur-
chased from BD Transduction Laboratories (Franklin Lakes, NJ, USA).
Antibody toβ-arrestinswas provided byDr. Lefkowitz (DukeUniversity,
Durham, NC, USA).
2.2. Plasmid constructs
Wild-type human D2 receptor (short form) and D3 receptor were
reported previously [12]. The D2 and D3 receptors were tagged with
the M2-FLAG epitope (DYKDDDDA) at the N-terminus, inserted after
Met1. Chimeric receptors with exchanged N-termini (D2R-D3NT and
D3R-D2NT), WT-D2 and D3R-D2NT receptor glycosylation mutants
(N5Q/N17Q/N23Q), a series of N-terminus deletion mutants (from Δ2
to Δ20), D3R glycosylation mutants (N12Q, N19Q, N11Q/N19Q, N97Q/
N173Q, N12Q/N19Q/N97Q/N173Q), and a D2R-D3NT (N12Q/N19Q)
glycosylation mutant were produced by site-directed mutagenesis
and subcloned into pCMV5. Some constructs were FLAG-tagged at the
N-terminus or GFP-tagged at the C-terminus. Small hairpin RNAs for
clathrin heavy chain, caveolin-1, GRK2, and β-arrestins were used as
described previously [13–16]. To study the effects of tunicamycin
treatment on ligand binding, signaling, and internalization, we adjusted
the amount of plasmids for transfection (2–3 times more plasmids were
used in the tunicamycin-treated groups compared to the vehicle-
treated groups).
2.3. Determination of ligand-binding properties
HEK-293 cells expressing D2 or D3 receptors were incubated with
2.2 or 7.2 nM [3H]-sulpiride and with increasing concentrations of DA
(10−9–10−4 M for D2 receptor, 10−13–10−8 M for D3 receptor) for
150 min at 4 °C [17]. Cells were washed three times with ice-cold
serum-free Minimum Essential Medium containing 10 mM HEPES,
pH 7.4, lysed with 1% sodium dodecyl sulfate (SDS), and counted
using a liquid scintillation counter.2.4. Receptor internalization assay
D2 and D3 receptor internalizationwas assessed based on the hydro-
philic properties of [3H]-sulpiride [17]. HEK-293 cells expressing the D2
or D3 receptor were seeded 1 day post-transfection at a density of
1.5 × 105 cells/well in 24-well plates. On the following day, cells were
rinsed once and pre-incubated with 0.5 ml of pre-warmed, serum-free
media containing 10 mM HEPES, pH 7.4, for 15 min at 37 °C. Subse-
quently, cells were stimulated with 10 μM DA for 60 min or 100 nM
PMA for 30 min. Cells were incubated with 250 μl [3H]-sulpiride (ﬁnal
concentration of 2.2 nM for D2 receptor and 7.2 nM for D3 receptor) at
4 °C for 150 min in the presence and absence of 10 μM haloperidol.
Cells were washed and then lysed with 1% SDS. Remaining radioactivity
was counted using a liquid scintillation counter.
2.5. Immunoprecipitation
Cells were lysed in lysis buffer (150 mM NaCl, 50 mM Tris, pH 7.4,
1 mM EDTA, 1% Triton X-100, 10% glycerol) on a rotation wheel for
1 h at 4 °C. Supernatant was combined with 20 μl of a 50% slurry of
anti-FLAG agarose beads for 2–3 h on a rotation wheel. Beads were
washed with washing buffer (50 mM Tris, pH 7.4, 137 mM NaCl, 10%
glycerol, 1% NP-40) three times for 10min each. The resulting immuno-
precipitates were analyzed by immunoblotting.
2.6. Endo H and PNGase F cleavage
Crude membrane fractions were obtained from cells expressing
FLAG-taggedD2 orD3 receptor according to protocols describedprevious-
ly [18]. Cell lysates were further solubilized with RIPA buffer (150 mM
NaCl, 50mMTris, pH 7.4, 1% NP-40, 0.5% deoxycholate, 0.1% SDS). Immu-
noprecipitates were dissolved in 30 μl denaturing buffer (0.5% SDS, 1%
β-mercaptoethanol) and heated at 65 °C for 20 min. Samples were
then treatedwith 10 units/μl EndoHor PNGase F at 37 °C for 4 h. Samples
were heated at 65 °C for 20 min and analyzed by immunoblotting.
2.7. Whole cAMP assay
Cellular cAMPwasmeasured through an indirectmethod: a reporter
plasmid containing the ﬁreﬂy luciferase gene under control of cAMP
response elements and a pRL-TK control vector [19]. Transfected cells
were seeded in 24-well plates, and each transfection set was organized
into three identical groups. Cells were treated with 2 μM forskolin and
quinpirole (10−13–10−8 M) for 4 h and harvested. Relative luciferase
expression was measured using a dual luciferase assay kit (Promega,
Madison, WI, USA). Data were normalized by expressing the cAMP
level as a percentage of forskolin-stimulated cAMP in each experiment.
Dose–response curves were ﬁtted with the GraphPad Prism software
(GraphPad, San Diego, CA, USA).
2.8. Confocal microscopy
One day post-transfection, cells were seeded onto the 35-mmconfo-
cal dishes, which contain a 1-cm well in the center sealed by a glass
coverslip on the bottom. Cells were allowed 1 day to recover, and then
were examined with a TCS SP5/AOBS/Tandem laser scanning confocal
microscope (Leica, Jena, Germany).
2.9. Primary brain cell culture
Culture of primary rat brain cortical neuronal cultures was described
previously [20]. Cells were transfected using Lipofectamine® 2000
(Invitrogen, Carlsbad, CA, USA). Cells were observed with an LSM 710
confocal microscope (Carl Zeiss, Oberkochen, Germany).
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All data are expressed as means ± SEM. Comparisons among
groupswere shown using two-way analysis of variancewith Bonferroni
post-tests. Student's t-test was also used to compare results between
groups.
3. Results
3.1. Functional characterization of the N-terminus of dopamine D3 receptors
The crystal structure of theD3 receptorwas previously reported [21].
However, details regarding the N-terminus attached at the 1st trans-
membrane domain (TM) have not been resolved due to its high ﬂexibil-
ity in the crystal. The N-terminal regions of GPCRs are highly variable.
Alignment of amino acid sequences of the N-terminal regions of D2
and D3 receptors show that they are disparate in composition, except
for several amino acid residues near the 1st TM (Fig. 1A).
The functional roles of the N-terminus were studied by sequentially
deleting the amino acid residues from the beginning of the D3 receptor.
Total amount of receptor was not affected by deletion up to 20 amino
acid residues within the N-terminus (Fig. S1A) but surface expression
was signiﬁcantly inhibited bydeletion of as few as 5 amino acid residues
(Fig. S1B). The decrease in surface expression was not due to altered
afﬁnity of the receptor to the radioligand, [3H]-sulpiride (Fig. S1C).
Moreover, the last 4 amino acids in the N-terminus of the D3 receptor
were important for D3 receptor desensitization (Fig. S1D and S1E).T
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Fig. 1. Effect of tunicamycin treatment on dopamine D2 and D3 receptors migration in sodium
theN-terminal regions of thehumanD2 andD3 receptors. Potential glycosylation sites on theD2
and FLAG-tagged D2 receptor or D3 receptor were treated either with vehicle or 1 μg/ml tunicam
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and immunoblottedwith antib
malized by including pEGFP vector. (D, E) Cells were transfected with FLAG-tagged D2 or D3 re
were treatedwith endoglycosidase H (Endo H) or peptide N-glycosidase F (PNGase F). Samples
from at least ﬁve independent experiments.Because this region contains two N-linked glycosylation sites
(N12 and N19), we tested the involvement of glycosylation in surface
expression. As shown in Fig. S1F, inhibition of D3 receptor glycosylation
by treatment with tunicamycin (1 μg/ml, 24 h) yielded similar out-
comes as the glycosylation mutant (Δ(2–20)). These results suggest
that glycosylation on the N-terminus of D3 receptor could serve impor-
tant roles in various receptor functions.
3.2. Both dopamine D2 and D3 receptors are glycosylated
Tunicamycin inhibits the synthesis of N-linked glycoproteins and
has been used to study the functional roles of glycosylation. When
cells were treated with tunicamycin, the molecular weights of D2 and
D3 receptors, as observed by SDS-polyacrylamide gel electrophoresis
(SDS-PAGE), decreased (Fig. 1B and 1C). With tunicamycin treatment
(1 μg/ml, 24 h), a protein band at approximately 45 kDa shifted lower
on the gel, suggesting that both the D2 and D3 receptors are glycosylated.
These results were conﬁrmed by treatment with enzymes that remove
glycans. For example, Endo H selectively removes N-linked glycans with
high mannose and/or hybrid types from glycoproteins, but does not re-
move the complex type [22]. PNGase F removes all N-linked glycans
from glycoproteins [23]. Glycoproteins, which are correctly processed
through the endoplasmic reticulum and Golgi apparatus, become
resistant to Endo H. In agreement with this, the cell lysates from cell
membranes containing D2 or D3 receptors were sensitive to PNGase F,
and exhibited a protein band shift from 45 kDa to approximately
35 kDa (Fig. 1D and 1E).- + +
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dodecyl sulfate-polyacrylamide gel electrophoresis. Alignment of amino acid sequences in
andD3 receptors are shown in red. (B, C) Cells expressing green ﬂuorescence protein (GFP)
ycin for 24 h. Cell lysateswere immunoprecipitatedwith FLAG beads, analyzed by sodium
odies to FLAG (immunoprecipitates) and GFP (lysates). Transfection efﬁciencieswere nor-
ceptor, and cell lysates were immunoprecipitated with FLAG beads. Immunoprecipitates
were analyzed by SDS-PAGE and blottedwith FLAG antibody. Data (B–E) represent results
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and D3 receptors
To test the effect of deglycosylation on the receptor afﬁnities for
agonist, cells were treated with tunicamycin and radioligand/agonist
competition experiments were conducted. As shown in Fig. 2A and 2B,
a change in D2 andD3 receptor afﬁnity for DAwas not evidentwhen gly-
cosylation was inhibited. This was expected because the ligand-binding
pockets of the D2 and D3 receptors are buried within the transmem-
brane domains, away from the N-terminus [21,24].
Next, we tested the effects of deglycosylation on cell surface expres-
sion of the D2 and D3 receptors. Treatment of cells with tunicamycin in-
creased localization of receptors in the cytosol (Fig. 2C). The proportion
of D2 and D3 receptors on the cell surface (cell surface/total) decreased
by about 20% and 50%, respectively (Fig. 2C).
3.4. Identiﬁcation of N-linked glycosylation sites of the D3 receptor
Four possible N-linked glycosylation sites are located within the ex-
tracellular region of the D3 receptor (N12, N19, N97, and N173; Fig. 3A)A BD2R
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vehicle or with 1 μg/ml tunicamycin for 24 h. Cells expressing D2 or D3 receptors were incuba
dopamine (DA) for 1 h at room temperature in the presence or absence of 10 μM haloperido
and then were counted using a liquid scintillation counter. The Ki value of DA for D2 recepto
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bar represents 10 μM.Ratio of cell surface/totalwas determinedwith binding studies using [3H]-
tively. Each data point represents mean ± SEM (n = 3). Data represent results from two inde[6,25], these sitesweremutated either individually or in combination by
site-directed mutagenesis. As observed with tunicamycin treatment,
the 45-kDa protein band disappeared and a new band about 35 kDa
appeared with N12Q/N19Q- and N97Q/N173Q-D3R (Fig. 3B). If the D3
receptor was glycosylated on both the N-terminus and extracellular
loop, we expected that the 35 kDa bandwould be observedwith another
receptor band of higher molecular weight. However, it was not clear
whether the N12/19Q- and N97/N173Q-D3R receptor bands were
different from that of the WT-D3 receptor treated with tunicamycin. We
speculate that glycosylation on the N-terminus and extracellular loops
might exert a mutual regulatory effect.
Individualmutation of the four potentialN-linked glycosylation sites
did not have any effect on cell surface expression of the D3 receptor
(Fig. 3C). The simultaneous mutation of N12 and N19 residues (N12Q/
N19Q), but not N97 and N173 residues (N97Q/N173Q), resulted in de-
creased cell surface expression of D3. The mutations of all four possible
N-linked glycosylation sites (N12Q/N19Q/N97Q/N173Q) did not further
decrease D3 receptor surface expression compared to the N12Q/N19Q
mutant. These results suggest that N-linked glycosylation on the
N-terminus is involved in receptor cell surface expression. MutationD3R
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suggesting that N12 and N19 may compensate for each other when
one is blocked. These resultswere conﬁrmed by observing the subcellu-
lar distribution of GFP-tagged D3 receptor in HEK-293 cells. The WT-D3
receptor and the individually mutated receptors were found primarily
on the plasma membrane, while the doubly mutated receptors were
found in the perinuclear regions and in the cytosol (Fig. 3D). Similar re-
sults were observed in the primary cultured cortical neurons (Fig. 3E).3.5. Different functional roles of glycosylation on the D3 receptor N-terminus
and extracellular loops
Because glycosylation occurs on both theN-terminus and extracellu-
lar loops of the D3 receptor, we predicted that glycosylation may have
different functions for different domains. Mutation of the glycosylation
sites on the N-terminus (N12, N19) inhibited both D3 receptor signaling
and desensitization (Fig. 4A). In contrast, the mutation of the N97 and
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and desensitization (Fig. 4B). In agreement with these results, deletion
of the N-terminus region of the D3 receptor containing N-linked glyco-
sylation sites abolished desensitization (Fig. S1E). In case of D2 receptor,
mutation of consensus N-linked glycosylation sites (Fig. S2A) or treat-
ment with tunicamycin (Fig. S2B) did not affect signaling. These results
again suggest that functional roles of N-linked glycosylation are highly
dependent of molecular environments surrounding glycosylation sites,
such as sequence homology and location of N-linked glycosylation site
within the receptor.
Next, the role of glycosylation on D3 receptor internalization was
tested for using PMA-induced internalization since it was reported
that PKC-mediated internalization is the major endocytic pathway
of D3 receptor [26]. Mutation of the glycosylation sites on both the
N-terminus (Fig. 4C) and the extracellular loops (Fig. 4D) inhibited
D3 receptor internalization.3.6. Glycosylation on the N-terminus regulates cell surface expression of D2
and D3 receptor independent of the respective N-terminus
Additional studies were conducted to test whether the roles of
glycosylation on receptor function are determined by speciﬁc character-
istics of theN-terminus. To answer this question,we generated chimeric
D2 and D3 receptors, in which the respective N-termini were exchanged
(Fig. 5A). Glycosylation of the chimeric receptorswas inhibited either by
treating with tunicamycin or by mutating the consensus glycosylation
sites, and the resulting receptors were tested for surface expression
and internalization.Interestingly, the newly introduced N-termini inﬂuenced surface
expression of the chimeric receptors. As shown in Fig. 5B, surface ex-
pression of the D2 receptor decreased with its substitution by the D3 re-
ceptor N-terminus, and surface expression of the D3 receptor increased
with its substitution by the D2 receptor N-terminus.When the N-linked
glycosylation sites on the N-termini were mutated, surface expression
of each chimeric receptor was inhibited. In agreement with these
results, inhibition of glycosylation with tunicamycin reduced surface
expression of each chimeric receptor (Fig. 5C). These results suggest
that N-linked glycosylation is critical in determining proper cell surface
receptor expression, independent of the respective N-terminus.
3.7. Glycosylation on D2 and D3 N-termini exerts opposite effects on
receptor internalization
Next, we tested the effects of N-terminus glycosylation on receptor
internalization. DA- and PMA-induced internalization was employed
for D2 and D3 receptors, respectively, because they are the primary in-
ternalization pathways for the receptors [26]. Receptor internalization
increased when glycosylation of the WT-D2 receptor was inhibited
by tunicamycin treatment (Fig. 6A) or with mutation of consensus
N-terminus glycosylation sites (Fig. 6B, WT vs. GlyX). Similarly, receptor
internalization increased with mutation of glycosylation sites in the
chimeric D2 receptor in which the N-terminus was replaced with that of
the D3 receptor (D2R-D3NT) (Fig. 6B, D3NT vs. D3NT-GlyX).
PMA-induced internalization decreased when glycosylation of
the WT-D3 receptor was inhibited by tunicamycin (Fig. 6C) or when
N-terminus glycosylation sites were mutated (Fig. 6D, WT vs. GlyX).
Similarly, mutation of glycosylation sites of the chimeric receptor,
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(Fig. 6D, D2NT vs. D2NT-GlyX). These results suggest that N-linked gly-
cosylation on the N-terminus represses and facilitates internalization
of the D2 and D3 receptors, respectively, independent of the respective
N-terminus.
3.8. Glycosylation on the N-terminus determines endocytic pathway
selection of D2 and D3 receptor
Because glycosylation of the N-terminus plays important roles in the
internalizations of D2 andD3 receptors,molecularmechanisms underly-
ing their regulation was further examined. To examine whether glyco-
sylation on the N-terminus determines the endocytic routes through
clathrin-coated pits or caveolae, clathrin heavy chains (CHC) were
knocked down by stable transfection of shRNA or cells were treated
with MβCD (methyl-β-cyclodextrin) which disrupts caveolae [27].
Internalization of the D2 receptor and D2R-D3NT increased approxi-
mately twofold with N-terminus deglycosylation. With cellular CHC
knockdown, internalization of both receptors was signiﬁcantly inhibited
regardless of glycosylation status (Fig. 7A). In contrast, knockdown of
caveolin-1 inhibited internalization of the D2 receptor and D2R-D3NT by
approximately 50%, but did not affect internalization of deglycosylatedmutants (Fig. 7B). Essentially the same results were obtained from the
cells treated with 3 mMMβCD (Fig. S3A), suggesting that the glycosyla-
tion of D2 receptor is required for caveolae-dependent internalization of
D2 receptor, independent of the respective N-terminus.
Internalization of both the WT-D3 receptor and D3R-D2NT were
inhibited by mutation of consensus N-lined glycosylation sites on the
N-terminus (Fig. 7C, Con-KD). Knockdown of CHC selectively inhibited
internalization of receptors with intact glycosylation sites by approxi-
mately 50% (Fig. 7C, compare between Con-KD and CHC-KD). In con-
trast, knockdown of caveolin-1 did not affect internalization of either
the WT-D3 receptor or D3R-D2NT, regardless of glycosylation status of
the N-terminus (Fig. 7D). Virtually the same results were obtained
from the cells treated with 3 mMMβCD (Fig. S3B), suggesting that gly-
cosylation of the D3 receptor on the N-terminus is required for clathrin-
dependent internalization, independent of the respective N-terminus.
Thus, our results overall suggest that the N-linked glycosylation
on the N-terminus is involved in the regulation of the endocytosis
of D2 and D3 receptor. In case of D2 receptor, only glycosylated ones un-
dergo caveolar endocytosis; both glycosylated and deglycosylated D2
receptors undergo endocytosis through clathrin-mediated pathway.
On the other hand, D3 receptors undergo glycosylation-dependent
clathrin-mediated endocytosis.
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internalization of the D2 and D3 receptors by regulating interaction with
caveolin-1 and clathrin
To understand the molecular basis for the N-linked glycosylation on
microdomain-speciﬁc receptor internalization, we tested the interac-
tions between receptor and cellular components responsible for recep-
tor endocytosis, includingGRK, β-arrestin, PKC, clathrin, and caveolin-1.
Knockdown of GRK2 or β-arrestins did not inhibit the effects of
tunicamycin on DA-induced internalization of D2 receptor (Fig. S4A
and S4B). However, tunicamycin treatment did inhibit the interaction
between D2R and caveolin-1, but did not affect interactionwith clathrin
(Fig. 8A). These results are consistent with the results in Fig. S3A, in
which the treatment with MβCD failed to inhibit the internalization of
D2R-GlyX. Thus, glycosylation on the N-terminus of the D2 receptor is
required for interaction with caveolin-1; further, N-terminus glycosyla-
tion plays important roles in intracellular trafﬁcking by selectively
directing receptors toward the caveolae pathway.
In the case of the D3 receptor, PMA-induced internalization was
inhibited by deglycosylation independent of the respective N-terminus
(Fig. 6D), but in a clathrin-dependent manner (Fig. 7C). As expected,
the interaction with clathrin was inhibited by tunicamycin treatment
(Fig. 8B). Interaction between the D3 receptor and PKCβwas not affected
(Fig. S4C). These results suggest that N-linked glycosylation on the
N-terminus regulates receptor internalization by controlling the asso-
ciation with different microdomains on the plasma membrane.
Since our results demonstrated that the N-linked glycosylation deter-
mines the endocytosis D2 and D3 receptor within speciﬁc microdomains,
we were curious whether glycosylation of each receptor normally occurswithin speciﬁcmicrodomains. As shown in the upper panel of Fig. 8C, the
D3 receptor was normally glycosylated in clathrin-KD cells where the re-
ceptor endocytosis was inhibited in a glycosylation-dependent manner.
D2 receptor was also normally glycosylated in Cav1-KD cells (lower
panel).
4. Discussion
Glycosylation differentially affects GPCR function, depending upon
the speciﬁc receptor and the cell type. Thus, it is difﬁcult to identify gen-
eral principles governing glycosylation-mediated regulation of receptor
function. Here, we employed the dopamine D2 and D3 receptors as an
experimental model. Because the receptors are highly homologous at
the amino acid level and similar with respect to pharmacology and sig-
naling, we expected our experiments to reveal the principles dictating
the functional roles of glycosylation.
On SDS-PAGE, the molecular weights of D2 and D3 receptors
decreased by 7–10 kDa when deglycosylated with Endo H or PNGase F
(Fig. 1). Considering that the N-termini of the D2 and D3 receptors con-
tain only 37 amino acid (4.5 kDa) and 32 amino acid (3.4 kDa) residues,
respectively, glycosylation imposes a signiﬁcant amount of weight and
volume on the N-terminus of each receptor. The attached glycans may
provide a larger and potentially more ﬂexible binding surfaces and
add negative charge to the N-terminus of the GPCRs [15].
One speciﬁc aim in this studywas to understand the functional roles
of glycosylation on theN-terminus of GPCRs in termsof speciﬁcity of the
N-terminus. As illustrated in Fig. 9, our study showed that N-linked
glycosylation on the N-terminus plays important roles in determining
the various receptor properties and functions. This was required for
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speciﬁc microdomain. Both activities occurred independent of which
N-terminus, D2 or D3, was attached. For signaling, glycosylation on the
N-terminus of the D3 receptor was required for basal signaling and
desensitization.
The roles of N-linked glycosylation on the N-terminus in correct cell
surface expression are consistentwith a previous study, inwhich the in-
hibition of glycosylation was shown to decrease surface expression of
the D2 receptor by interfering with the calnexin interaction [10]. Inhibi-
tion of glycosylation interferes with cell surface expressions of other
GPCRs, including the thyrotropin receptor [28], β1 adrenergic receptor[29], and protease-activated receptor type 2 [30]. Thus, it is postulated
that one important role of glycosylation is to regulate the surface
expressions of GPCRs.
It is clear that N-linked glycosylation of the D3 receptor on the
N-terminus is responsible for surface expression, desensitization, and
internalization. It should be noted, however, thatN-linked glycosylation
within the extracellular loops is exclusively responsible for internaliza-
tion. Similar results were reported previously. For example, glycosyla-
tion on the N-terminus and within the 2nd extracellular loop of
protease-activated receptor type 1 (PAR1) are important for transport
to the cell surface and internalization, respectively [31]. Similar were
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are needed to identify a common principle dictating the functional
roles of glycosylation of the extracellular loop.Caveolae
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51C. Min et al. / Biochimica et Biophysica Acta 1853 (2015) 41–51speciﬁc plasma membrane microdomains of integral proteins. For ex-
ample, glycosylation of Edg-1, a receptor for sphingosine-1-phosphate,
is required for agonist-induced internalization and associationwith cave-
olae [33]. Introduction of N-linked glycosylation sites to the basolateral
Na+, K+-ATPase β1 subunit results in its clustering in caveolae [34].
However, the understanding the detailed mechanisms involved in the
glycosylation-mediated associations between the receptor and the
constituents of plasma membrane microdomains requires further study.
The main purpose of this study was to identify general principles
governing the functional roles of glycosylation on GPCR functions. Our
results show that the functional roles of glycosylation are too diverse
to be generalized based on the structural and functional homology be-
tween the dopamine D2 and D3 receptors. However, our results indicate
that N-linked glycosylation on the N-terminus of both the D2 and D3 re-
ceptors are involved in the selection of endocytic pathways through
speciﬁc microdomains. Additional studies in more controlled experi-
mental systems could provide a valuable answer to the fundamental
question—what determines endocytic pathways selection for speciﬁc
GPCRs?
Because glycosylation status strongly inﬂuences the various func-
tional properties of D3 receptor, it would be interesting to examine the
glycosylation patterns of D3 receptor in different regions of the brain
and in pathological conditions involving D3 receptors. A similar case
was reported with dopamine transporters, which are co-expressed
with theD3 receptor in dopaminergic neurons that are differentially gly-
cosylated dependingwhere they are expressed in the brain regions [35].
Additionally, another study reported that dopamine transporter glyco-
sylation is correlated with vulnerability of midbrain dopaminergic
cells in Parkinson's disease [36].
Acknowledgement
This researchwas ﬁnancially supported by theMinistry Of Trade, In-
dustry & Energy (MOTIE) &Korea Institute for Advancement of Technol-
ogy (KIAT) through the Inter-ER Cooperation Project (R0002020).
Appendix A. Supplemental data
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamcr.2014.09.024.
References
[1] J. Bockaert, J.P. Pin, Molecular tinkering of G protein-coupled receptors: an evolu-
tionary success, EMBO J. 18 (1999) 1723–1729.
[2] K. Kristiansen, Molecular mechanisms of ligand binding, signaling, and regulation
within the superfamily of G-protein-coupled receptors: molecular modeling and
mutagenesis approaches to receptor structure and function, Pharmacol. Ther. 103
(2004) 21–80.
[3] S. Filipek, R.E. Stenkamp, D.C. Teller, K. Palczewski, G protein-coupled receptor
rhodopsin: a prospectus, Annu. Rev. Physiol. 65 (2003) 851–879.
[4] A. Ulloa-Aguirre, C. Timossi, P. Damian-Matsumura, J.A. Dias, Role of glycosylation in
function of follicle-stimulating hormone, Endocrine 11 (1999) 205–215.
[5] M. Wheatley, S.R. Hawtin, Glycosylation of G-protein-coupled receptors for
hormones central to normal reproductive functioning: its occurrence and role,
Hum. Reprod. Update 5 (1999) 356–364.
[6] D.I. Cho, M. Zheng, K.M. Kim, Current perspectives on the selective regulation of
dopamine D and D receptors, Arch. Pharm. Res. 33 (2010) 1521–1538.
[7] K.R. Jarvie, H.B. Niznik, Deglycosylation and proteolysis of photolabeled D2 dopamine
receptors of the porcine anterior pituitary, J. Biochem. 106 (1989) 17–22.
[8] C. David, C.S. Fishburn, F.J. Monsma Jr., D.R. Sibley, S. Fuchs, Synthesis and processing
of D2 dopamine receptors, Biochemistry 32 (1993) 8179–8183.
[9] C.S. Fishburn, Z. Elazar, S. Fuchs, Differential glycosylation and intracellular trafﬁck-
ing for the long and short isoforms of the D2 dopamine receptor, J. Biol. Chem. 270
(1995) 29819–29824.
[10] R.B. Free, L.A. Hazelwood, D.M. Cabrera, H.N. Spalding, Y. Namkung, M.L. Rankin, D.R.
Sibley, D1 and D2 dopamine receptor expression is regulated by direct interaction
with the chaperone protein calnexin, J. Biol. Chem. 282 (2007) 21285–21300.[11] D. Cho, M. Zheng, C. Min, K. Kwon, C. Shin, H. Choi, K. Kim, ARF6 and GASP-1 are
post-endocytic sorting proteins selectively involved in GRK- and PKC-mediated in-
tracellular trafﬁcking of dopamine D2 receptor in the transfected cells, Br. J.
Pharmacol. 168 (2013) 1355–1374.
[12] K.M. Kim, K.J. Valenzano, S.R. Robinson, W.D. Yao, L.S. Barak, M.G. Caron, Differential
regulation of the dopamine D2 and D3 receptors by G protein-coupled receptor
kinases and beta-arrestins, J. Biol. Chem. 276 (2001) 37409–37414.
[13] N. Marina-Garcia, L. Franchi, Y.G. Kim, Y. Hu, D.E. Smith, G.J. Boons, G. Nunez,
Clathrin- and dynamin-dependent endocytic pathway regulates muramyl dipeptide
internalization and NOD2 activation, J. Immunol. 182 (2009) 4321–4327.
[14] Q. Guo, H. Subramanian, K. Gupta, H. Ali, Regulation of C3a receptor signaling in
human mast cells by G protein coupled receptor kinases, PLoS ONE 6 (2011)
e22559.
[15] X. Zhang, F. Wang, X. Chen, Y. Chen, L. Ma, Post-endocytic fates of delta-opioid
receptor are regulated by GRK2-mediated receptor phosphorylation and distinct
beta-arrestin isoforms, J. Neurochem. 106 (2008) 781–792.
[16] S. Thomas, J.B. Overdevest, M.D. Nitz, P.D. Williams, C.R. Owens, M. Sanchez-
Carbayo, H.F. Frierson, M.A. Schwartz, D. Theodorescu, Src and caveolin-1 recipro-
cally regulate metastasis via a common downstream signaling pathway in bladder
cancer, Cancer Res. 71 (2011) 832–841.
[17] C. Min, M. Zheng, X. Zhang, M.G. Caron, K.M. Kim, Novel roles for beta-arrestins in
the regulation of pharmacological sequestration to predict agonist-induced desensi-
tization of dopamine D3 receptors, Br. J. Pharmacol. 170 (2013) 1112–1129.
[18] C.Min, D.I. Cho, K.J. Kwon, K.S. Kim, C.Y. Shin, K.M. Kim, Novel regulatorymechanism of
canonical Wnt signaling by dopamine D2 receptor through direct interaction with
beta-catenin, Mol. Pharmacol. 80 (2011) 68–78.
[19] M. Zheng, S.Y. Cheong, C.Min, M. Jin, D.I. Cho, K.M. Kim, Beta-arrestin2 plays permis-
sive roles in the inhibitory activities of RGS9-2 on G protein-coupled receptors
by maintaining RGS9-2 in the open conformation, Mol. Cell. Biol. 31 (2011)
4887–4901.
[20] K.J. Kwon, J.N. Kim, M.K. Kim, J. Lee, L.J. Ignarro, H.J. Kim, C.Y. Shin, S.H. Han, Melatonin
synergistically increases resveratrol-induced heme oxygenase-1 expression through
the inhibition of ubiquitin-dependent proteasome pathway: a possible role in neuro-
protection, J. Pineal Res. 50 (2011) 110–123.
[21] E.Y. Chien, W. Liu, Q. Zhao, V. Katritch, G.W. Han, M.A. Hanson, L. Shi, A.H. Newman,
J.A. Javitch, V. Cherezov, R.C. Stevens, Structure of the human dopamine D3 receptor
in complex with a D2/D3 selective antagonist, Science 330 (2010) 1091–1095.
[22] J.H. Elder, S. Alexander, Endo-beta-N-acetylglucosaminidase F: endoglycosidase
from Flavobacterium meningosepticum that cleaves both high-mannose and com-
plex glycoproteins, Proc. Natl. Acad. Sci. U. S. A. 79 (1982) 4540–4544.
[23] A.L. Tarentino, C.M. Gomez, T.H. Plummer Jr., Deglycosylation of asparagine-linked
glycans by peptide:N-glycosidase F, Biochemistry 24 (1985) 4665–4671.
[24] F. Boeckler, P. Gmeiner, The structural evolution of dopamine D3 receptor ligands:
structure–activity relationships and selected neuropharmacological aspects,
Pharmacol. Ther. 112 (2006) 281–333.
[25] C. Missale, S.R. Nash, S.W. Robinson, M. Jaber, M.G. Caron, Dopamine receptors: from
structure to function, Physiol. Rev. 78 (1998) 189–225.
[26] E.Y. Cho, D.I. Cho, J.H. Park, H. Kurose, M.G. Caron, K.M. Kim, Roles of protein kinase C
and actin-binding protein 280 in the regulation of intracellular trafﬁcking of
dopamine D3 receptor, Mol. Endocrinol. 21 (2007) 2242–2254.
[27] S.K. Rodal, G. Skretting, O. Garred, F. Vilhardt, B. van Deurs, K. Sandvig, Extraction of
cholesterol with methyl-beta-cyclodextrin perturbs formation of clathrin-coated
endocytic vesicles, Mol. Biol. Cell 10 (1999) 961–974.
[28] D. Russo, G.D. Chazenbalk, Y. Nagayama, H.L. Wadsworth, B. Rapoport, Site-directed
mutagenesis of the human thyrotropin receptor: role of asparagine-linked oligosac-
charides in the expression of a functional receptor, Mol. Endocrinol. 5 (1991) 29–33.
[29] J. He, J. Xu, A.M. Castleberry, A.G. Lau, R.A. Hall, Glycosylation of beta(1)-adrenergic
receptors regulates receptor surface expression and dimerization, Biochem. Biophys.
Res. Commun. 297 (2002) 565–572.
[30] S.J. Compton, S. Sandhu, S.J. Wijesuriya, M.D. Hollenberg, Glycosylation of human
proteinase-activated receptor-2 (hPAR2): role in cell surface expression and signal-
ling, Biochem. J. 368 (2002) 495–505.
[31] A.G. Soto, J. Trejo, N-linked glycosylation of protease-activated receptor-1 second
extracellular loop: a critical determinant for ligand-induced receptor activation
and internalization, J. Biol. Chem. 285 (2010) 18781–18793.
[32] Z. Zhang, S.C. Austin, E.M. Smyth, Glycosylation of the human prostacyclin receptor:
role in ligand binding and signal transduction, Mol. Pharmacol. 60 (2001)
480–487.
[33] T. Kohno, A. Wada, Y. Igarashi, N-glycans of sphingosine 1-phosphate receptor Edg-
1 regulate ligand-induced receptor internalization, FASEB J. 16 (2002) 983–992.
[34] O. Vagin, S. Turdikulova, G. Sachs, Recombinant addition of N-glycosylation sites to
the basolateral Na, K-ATPase beta1 subunit results in its clustering in caveolae and
apical sorting in HGT-1 cells, J. Biol. Chem. 280 (2005) 43159–43167.
[35] R. Lew, A. Patel, R.A. Vaughan, A. Wilson, M.J. Kuhar, Microheterogeneity of dopa-
mine transporters in rat striatum and nucleus accumbens, Brain Res. 584 (1992)
266–271.
[36] D. Afonso-Oramas, I. Cruz-Muros, D. Alvarez de la Rosa, P. Abreu, T. Giraldez, J.
Castro-Hernandez, J. Salas-Hernandez, J.L. Lanciego, M. Rodriguez, T. Gonzalez-
Hernandez, Dopamine transporter glycosylation correlates with the vulnerability
of midbrain dopaminergic cells in Parkinson's disease, Neurobiol. Dis. 36 (2009)
494–508.
